Congratulations to @YndigegnY for a successful defence of his PhD today (1st author of REDUCE-AMI trial https://t.co/jiQN40sXEG ) at the University of Lund (I was the external examiner) with supervisors @AlexSchiopu10 and @DavidErlinge This was a public examination with a https://t.co/O6OTqNhG9e
Beta-Blockers after Myocardial Infarction and Preserved Ejection Fraction.
Mentions
Extended reach
Total likes
Video views
Mentions per month
Apr 2024 – Oct 2025Where it's discussed
-
X / Twitter153 posts
-
News114 articles
-
YouTube18 videos
-
Blogs14 articles
-
Facebook11 posts
-
Bluesky3 posts
AI synopsis
What people are saying
Users are primarily commenting on recent studies indicating that beta-blockers may not provide benefits after MI for patients with preserved ejection fraction, using phrases like 'benefit is in question' and 'no diff for mortality,' which demonstrate analytical and cautious tones, reflecting a reassessment of longstanding practices based on the presented data.
Most discussions recognize the new evidence challenging the traditional use of beta-blockers post-MI in patients with preserved heart function.
The discussions reflect a moderate interest, with users contemplating how new data impacts clinical practice.
Comments analyze trial results, mention clinical implications, and cite sources, indicating a thoughtful engagement.
The discussions could influence perspectives on treatment protocols, showing a potential shift in practice based on new evidence.
Abstract in brief
- The study examined the effects of beta-blocker treatment on patients with acute myocardial infarction (MI) and preserved heart function, focusing on modern treatment protocols and advanced diagnostic methods.
- A total of 5020 patients were enrolled in a trial across multiple countries, and the results showed no significant difference in the occurrence of death or new MIs between the beta-blocker group and the control group over a median follow-up period of 3.5 years.
- Secondary outcomes, including overall mortality and hospitalizations for heart-related issues, were similar between the two groups, indicating that beta-blocker treatment may not confer additional benefits in this specific patient population.
Top posts
Most liked on X and BlueskyAmong patients with #AMI who underwent early coronary angiography and had a preserved LVEF (≥50%), long-term #betablocker vs no BB treatment did not ⬇️ composite primary end point of all cause death or new #myocardialinfarction https://t.co/Bir6c72xpr
Beta-Blockers after Myocardial Infarction and Preserved Ejection Fraction | New data #MI #BB https://t.co/yTIw266a5E
Interesting #REDUCE_AMI trial results @NEJM suggesting that #Beta_blockers do not confer reduction of mortality, hospitalisation or HF events if #LVEF was >50% @markcpetrie20 @BSHeartFailure @DrDavidWarriner @hvanspall @TheresaMcDonag3 #CardioTwitter https://t.co/gPaAee8lkU
Interpretação de Evidência: Beta bloqueador no Pós Infarto (Reduce-AMI) https://t.co/OoS1sWskg8 via @YouTube
En los pacientes con IAM que tenían una fracción de eyección ventricular izquierda conservada, el tratamiento betabloqueante a largo plazo no conllevó un menor riesgo de muerte o de nuevo IAM. https://t.co/X93ST1lNHR @secardiologia @Sociedad_SEMI
All mentions
Impact of Beta-Blockers After Myocardial Infarction with Preserved Heart Function
This video reviews a study analyzing the effects of beta-blocker treatment on patients with acute myocardial infarction and preserved ejection fraction, showing no significant differences in survival or recurrent MIs…
Evaluating Beta-Blocker Effectiveness in Patients with Preserved Heart Function Post-MI
This study examined the effects of beta-blocker treatment on patients with acute myocardial infarction and preserved heart function, focusing on modern treatment protocols and advanced diagnostic methods. Results showed…
Efficacy of Beta-Blockers After Myocardial Infarction with Preserved Heart Function
This video reviews a large multinational study examining the impact of beta-blocker treatment on patients with acute myocardial infarction and preserved ejection fraction, highlighting that beta-blockers may not…
Impella Use and Beta-Blockers After Myocardial Infarction Examined in Latest Studies
This week's podcast covers the Impella device's role in improving survival in STEMI cardiogenic shock and questions the benefits of beta-blockers post-MI with preserved ejection fraction, based on recent research.
Understanding Beta-Blocker Use After Myocardial Infarction with Preserved Heart Function
The study examined the effects of beta-blocker treatment on patients with acute myocardial infarction and preserved heart function, focusing on modern treatment protocols and advanced diagnostic methods. Results showed…
Aspirin Use in Prevention of Cardiovascular Disease: Expert Insights
Dr Samia Mora and Dr John Cleland discuss the indications for aspirin in primary and secondary prevention of atherosclerotic cardiovascular disease, highlighting recent evidence and clinical guidelines for treatment.
Recent Advances in Cardiology: Beta-Blockers, ATTR-CM, and RASi Management
This week's cardiology updates cover beta-blocker effects post-MI with preserved ejection fraction, new therapies for ATTR cardiomyopathy, and the benefits of holding RAS inhibitors before noncardiac surgery. For…
Reevaluating Beta-Blocker Use in Myocardial Infarction with Preserved Heart Function
This video reviews recent clinical trials on beta-blockers after MI with preserved ejection fraction, highlighting no significant benefit in reducing death or MIs based on a large international study over 3.5 years.
Evaluating Beta-Blockers Post-Myocardial Infarction with Preserved Heart Function
This week, Dr. John Mandrola discusses critical topics including CRT versus CSP, beta-blocker interruption after MI, and new approaches to LDL-C lowering and ICD decisions in cardiac sarcoidosis. The study examined the…
Effectiveness of Beta-Blockers After Heart Attack with Preserved Heart Function
This study examines the effects of beta-blocker treatment on patients with acute myocardial infarction and preserved heart function, indicating no significant benefit in reducing mortality or recurrent MIs over 3.5…
Cardiology 2024 Highlights and Predictions for 2025
BETABLOQUEADOR TRAS INFARTO. Tal vez no para todos
Beta-Blockers Lose Heart in Post-MI Patients with Normal LVEF #journalclub #myocardialinfarction
Friday MACE Club ???? ASSENT 2 E REDUCE AMI
Medical Portfolio Podcast: Best of the Month - April 2024
Medical Insights Beta Blockers in Post Heart Attack Care
Cardiovascular Screening Outcomes and Beta-Blocker Insights
This week, John Mandrola MD discusses key findings from the Danish Cardiovascular Screening Trial. The trial, involving over 46,000 men aged 65-74, showed no significant reduction in mortality but indicated lower rates…
Episode 1: Medical Insights Beta Blockers in Post Heart Attack Care
RT @GI_Pearls: @ebtapper @Gastronaut___ One would think it would be crazy to withhold beta blockers in patients with MI - but that’s exactl…
@ebtapper @Gastronaut___ One would think it would be crazy to withhold beta blockers in patients with MI - but that’s exactly what happened. And amazing result!! I will never forget being yelled at by cards fellows about beta blockers…https://t.co/Bp04HomwAK
RT @erlesen: Beta-Blockers after Myocardial Infarction without Reduced Ejection Fraction https://t.co/7C1JiYkPdk https://t.co/TYFp4f1OtI Be…
RT @mzkhalil: Beta-Blockers after Myocardial Infarction and Preserved Ejection Fraction | NEJM No benefits and it might be potentially har…
Beta-Blockers after Myocardial Infarction without Reduced Ejection Fraction https://t.co/7C1JiYkPdk https://t.co/TYFp4f1OtI Betablocker können lebensgefährlich sein. Allein in Deutschland nehmen nach Schätzungen 5,5 Millionen täglich Betablocker ein https://t.co/DOrP9Xnmy0
@bertraneli @escardio Meló encara major si tenim en compte aquest de l’any passat:
REDUCE-AMI didn’t show any difference in patients with preserved EF. https://t.co/282kRwbkEg
@JoseMaGarciaSua Les recomiendo ir a la fuente; no es exactamente así, parece que hay que repensar el tratamiento para la mitad de los pacientes, pero para la otra mitad es el tratamiento correcto: https://t.co/YSqGtIPJWo
Uno previo negativo. Todos tres ensayos confiables. Difícilmente lo resolveremos con un metaanálisis. https://t.co/zmNvc69RIJ
RT @SABOURETCardio: Beta-Blockers after Myocardial Infarction and Preserved Ejection Fraction | New data #MI #BB https://t.co/yTIw266a5E
RT @SABOURETCardio: Beta-Blockers after Myocardial Infarction and Preserved Ejection Fraction | New data #MI #BB https://t.co/yTIw266a5E
RT @SABOURETCardio: Beta-Blockers after Myocardial Infarction and Preserved Ejection Fraction | New data #MI #BB https://t.co/yTIw266a5E
Beta-Blockers after Myocardial Infarction and Preserved Ejection Fraction | New data #MI #BB https://t.co/yTIw266a5E
Rethinking Beta-blockers post-MI •REDUCE-AMI & ABYSS trials show no benefit of long-term beta-blockers post-MI in stable patients with preserved LV function. •Time to reconsider practice.
RT @hvanspall: Among patients with #AMI who underwent early coronary angiography and had a preserved LVEF (≥50%), long-term #betablocker vs…
RT @mzkhalil: Beta-Blockers after Myocardial Infarction and Preserved Ejection Fraction | NEJM No benefits and it might be potentially har…
RT @mzkhalil: Beta-Blockers after Myocardial Infarction and Preserved Ejection Fraction | NEJM No benefits and it might be potentially har…
RT @mzkhalil: Beta-Blockers after Myocardial Infarction and Preserved Ejection Fraction | NEJM No benefits and it might be potentially har…
Fuentes:
RT @hvanspall: Among patients with #AMI who underwent early coronary angiography and had a preserved LVEF (≥50%), long-term #betablocker vs…
RT @mzkhalil: Beta-Blockers after Myocardial Infarction and Preserved Ejection Fraction | NEJM No benefits and it might be potentially har…
RT @mzkhalil: Beta-Blockers after Myocardial Infarction and Preserved Ejection Fraction | NEJM No benefits and it might be potentially har…
RT @hvanspall: Among patients with #AMI who underwent early coronary angiography and had a preserved LVEF (≥50%), long-term #betablocker vs…
RT @hvanspall: Among patients with #AMI who underwent early coronary angiography and had a preserved LVEF (≥50%), long-term #betablocker vs…
RT @mzkhalil: Beta-Blockers after Myocardial Infarction and Preserved Ejection Fraction | NEJM No benefits and it might be potentially har…
RT @hvanspall: Among patients with #AMI who underwent early coronary angiography and had a preserved LVEF (≥50%), long-term #betablocker vs…
RT @hvanspall: Among patients with #AMI who underwent early coronary angiography and had a preserved LVEF (≥50%), long-term #betablocker vs…
RT @hvanspall: Among patients with #AMI who underwent early coronary angiography and had a preserved LVEF (≥50%), long-term #betablocker vs…
Among patients with #AMI who underwent early coronary angiography and had a preserved LVEF (≥50%), long-term #betablocker vs no BB treatment did not ⬇️ composite primary end point of all cause death or new #myocardialinfarction https://t.co/Bir6c72xpr
RT @mzkhalil: Beta-Blockers after Myocardial Infarction and Preserved Ejection Fraction | NEJM No benefits and it might be potentially har…
RT @mzkhalil: Beta-Blockers after Myocardial Infarction and Preserved Ejection Fraction | NEJM No benefits and it might be potentially har…
Beta-Blockers after Myocardial Infarction and Preserved Ejection Fraction | New England Journal of Medicine https://t.co/vdP3u2vVU2
RT @mzkhalil: Beta-Blockers after Myocardial Infarction and Preserved Ejection Fraction | NEJM No benefits and it might be potentially har…
RT @mzkhalil: Beta-Blockers after Myocardial Infarction and Preserved Ejection Fraction | NEJM No benefits and it might be potentially har…
RT @mzkhalil: Beta-Blockers after Myocardial Infarction and Preserved Ejection Fraction | NEJM No benefits and it might be potentially har…
RT @mzkhalil: Beta-Blockers after Myocardial Infarction and Preserved Ejection Fraction | NEJM No benefits and it might be potentially har…
RT @mzkhalil: Beta-Blockers after Myocardial Infarction and Preserved Ejection Fraction | NEJM No benefits and it might be potentially har…
RT @mzkhalil: Beta-Blockers after Myocardial Infarction and Preserved Ejection Fraction | NEJM No benefits and it might be potentially har…
RT @mzkhalil: Beta-Blockers after Myocardial Infarction and Preserved Ejection Fraction | NEJM No benefits and it might be potentially har…
RT @mzkhalil: Beta-Blockers after Myocardial Infarction and Preserved Ejection Fraction | NEJM No benefits and it might be potentially har…
RT @mzkhalil: Beta-Blockers after Myocardial Infarction and Preserved Ejection Fraction | NEJM No benefits and it might be potentially har…
RT @mzkhalil: Beta-Blockers after Myocardial Infarction and Preserved Ejection Fraction | NEJM No benefits and it might be potentially har…
RT @mzkhalil: Beta-Blockers after Myocardial Infarction and Preserved Ejection Fraction | NEJM No benefits and it might be potentially har…
RT @mzkhalil: Beta-Blockers after Myocardial Infarction and Preserved Ejection Fraction | NEJM No benefits and it might be potentially har…
RT @mzkhalil: Beta-Blockers after Myocardial Infarction and Preserved Ejection Fraction | NEJM No benefits and it might be potentially har…
RT @mzkhalil: Beta-Blockers after Myocardial Infarction and Preserved Ejection Fraction | NEJM No benefits and it might be potentially har…
RT @mzkhalil: Beta-Blockers after Myocardial Infarction and Preserved Ejection Fraction | NEJM No benefits and it might be potentially har…
RT @mzkhalil: Beta-Blockers after Myocardial Infarction and Preserved Ejection Fraction | NEJM No benefits and it might be potentially har…
RT @mzkhalil: Beta-Blockers after Myocardial Infarction and Preserved Ejection Fraction | NEJM No benefits and it might be potentially har…
RT @mzkhalil: Beta-Blockers after Myocardial Infarction and Preserved Ejection Fraction | NEJM No benefits and it might be potentially har…
RT @mzkhalil: Beta-Blockers after Myocardial Infarction and Preserved Ejection Fraction | NEJM No benefits and it might be potentially har…
RT @mzkhalil: Beta-Blockers after Myocardial Infarction and Preserved Ejection Fraction | NEJM No benefits and it might be potentially har…
RT @mzkhalil: Beta-Blockers after Myocardial Infarction and Preserved Ejection Fraction | NEJM No benefits and it might be potentially har…
RT @mzkhalil: Beta-Blockers after Myocardial Infarction and Preserved Ejection Fraction | NEJM No benefits and it might be potentially har…
RT @mzkhalil: Beta-Blockers after Myocardial Infarction and Preserved Ejection Fraction | NEJM No benefits and it might be potentially har…
RT @mzkhalil: Beta-Blockers after Myocardial Infarction and Preserved Ejection Fraction | NEJM No benefits and it might be potentially har…
RT @mzkhalil: Beta-Blockers after Myocardial Infarction and Preserved Ejection Fraction | NEJM No benefits and it might be potentially har…
RT @mzkhalil: Beta-Blockers after Myocardial Infarction and Preserved Ejection Fraction | NEJM No benefits and it might be potentially har…
RT @mzkhalil: Beta-Blockers after Myocardial Infarction and Preserved Ejection Fraction | NEJM No benefits and it might be potentially har…
RT @mzkhalil: Beta-Blockers after Myocardial Infarction and Preserved Ejection Fraction | NEJM No benefits and it might be potentially har…
REDUCE-AMI: Among patients with AMI who underwent early coronary angiography and had LVEF ≥50%, long-term beta-blocker treatment did not lead to a lower risk of the composite primary end point of death from any cause or new MI #MedTwitter https://t.co/t7as6sLS7C
RT @mzkhalil: Beta-Blockers after Myocardial Infarction and Preserved Ejection Fraction | NEJM No benefits and it might be potentially har…
RT @mzkhalil: Beta-Blockers after Myocardial Infarction and Preserved Ejection Fraction | NEJM No benefits and it might be potentially har…
RT @mzkhalil: Beta-Blockers after Myocardial Infarction and Preserved Ejection Fraction | NEJM No benefits and it might be potentially har…
RT @mzkhalil: Beta-Blockers after Myocardial Infarction and Preserved Ejection Fraction | NEJM No benefits and it might be potentially har…
RT @mzkhalil: Beta-Blockers after Myocardial Infarction and Preserved Ejection Fraction | NEJM No benefits and it might be potentially har…
RT @mzkhalil: Beta-Blockers after Myocardial Infarction and Preserved Ejection Fraction | NEJM No benefits and it might be potentially har…
RT @mzkhalil: Beta-Blockers after Myocardial Infarction and Preserved Ejection Fraction | NEJM No benefits and it might be potentially har…
RT @mzkhalil: Beta-Blockers after Myocardial Infarction and Preserved Ejection Fraction | NEJM No benefits and it might be potentially har…
RT @mzkhalil: Beta-Blockers after Myocardial Infarction and Preserved Ejection Fraction | NEJM No benefits and it might be potentially har…
RT @mzkhalil: Beta-Blockers after Myocardial Infarction and Preserved Ejection Fraction | NEJM No benefits and it might be potentially har…
RT @mzkhalil: Beta-Blockers after Myocardial Infarction and Preserved Ejection Fraction | NEJM No benefits and it might be potentially har…
RT @mzkhalil: Beta-Blockers after Myocardial Infarction and Preserved Ejection Fraction | NEJM No benefits and it might be potentially har…
RT @mzkhalil: Beta-Blockers after Myocardial Infarction and Preserved Ejection Fraction | NEJM No benefits and it might be potentially har…
RT @mzkhalil: Beta-Blockers after Myocardial Infarction and Preserved Ejection Fraction | NEJM No benefits and it might be potentially har…
RT @mzkhalil: Beta-Blockers after Myocardial Infarction and Preserved Ejection Fraction | NEJM No benefits and it might be potentially har…
RT @mzkhalil: Beta-Blockers after Myocardial Infarction and Preserved Ejection Fraction | NEJM No benefits and it might be potentially har…
RT @mzkhalil: Beta-Blockers after Myocardial Infarction and Preserved Ejection Fraction | NEJM No benefits and it might be potentially har…
RT @mzkhalil: Beta-Blockers after Myocardial Infarction and Preserved Ejection Fraction | NEJM No benefits and it might be potentially har…
RT @mzkhalil: Beta-Blockers after Myocardial Infarction and Preserved Ejection Fraction | NEJM No benefits and it might be potentially har…
RT @mzkhalil: Beta-Blockers after Myocardial Infarction and Preserved Ejection Fraction | NEJM No benefits and it might be potentially har…
RT @mzkhalil: Beta-Blockers after Myocardial Infarction and Preserved Ejection Fraction | NEJM No benefits and it might be potentially har…
RT @mzkhalil: Beta-Blockers after Myocardial Infarction and Preserved Ejection Fraction | NEJM No benefits and it might be potentially har…
RT @mzkhalil: Beta-Blockers after Myocardial Infarction and Preserved Ejection Fraction | NEJM No benefits and it might be potentially har…
RT @mzkhalil: Beta-Blockers after Myocardial Infarction and Preserved Ejection Fraction | NEJM No benefits and it might be potentially har…
RT @mzkhalil: Beta-Blockers after Myocardial Infarction and Preserved Ejection Fraction | NEJM No benefits and it might be potentially har…
RT @mzkhalil: Beta-Blockers after Myocardial Infarction and Preserved Ejection Fraction | NEJM No benefits and it might be potentially har…
RT @mzkhalil: Beta-Blockers after Myocardial Infarction and Preserved Ejection Fraction | NEJM No benefits and it might be potentially har…
RT @mzkhalil: Beta-Blockers after Myocardial Infarction and Preserved Ejection Fraction | NEJM No benefits and it might be potentially har…
RT @mzkhalil: Beta-Blockers after Myocardial Infarction and Preserved Ejection Fraction | NEJM No benefits and it might be potentially har…
RT @mzkhalil: Beta-Blockers after Myocardial Infarction and Preserved Ejection Fraction | NEJM No benefits and it might be potentially har…
RT @mzkhalil: Beta-Blockers after Myocardial Infarction and Preserved Ejection Fraction | NEJM No benefits and it might be potentially har…
RT @mzkhalil: Beta-Blockers after Myocardial Infarction and Preserved Ejection Fraction | NEJM No benefits and it might be potentially har…
RT @mzkhalil: Beta-Blockers after Myocardial Infarction and Preserved Ejection Fraction | NEJM No benefits and it might be potentially har…
RT @mzkhalil: Beta-Blockers after Myocardial Infarction and Preserved Ejection Fraction | NEJM No benefits and it might be potentially har…
RT @mzkhalil: Beta-Blockers after Myocardial Infarction and Preserved Ejection Fraction | NEJM No benefits and it might be potentially har…
RT @mzkhalil: Beta-Blockers after Myocardial Infarction and Preserved Ejection Fraction | NEJM No benefits and it might be potentially har…
RT @mzkhalil: Beta-Blockers after Myocardial Infarction and Preserved Ejection Fraction | NEJM No benefits and it might be potentially har…
RT @mzkhalil: Beta-Blockers after Myocardial Infarction and Preserved Ejection Fraction | NEJM No benefits and it might be potentially har…
RT @mzkhalil: Beta-Blockers after Myocardial Infarction and Preserved Ejection Fraction | NEJM No benefits and it might be potentially har…
RT @mzkhalil: Beta-Blockers after Myocardial Infarction and Preserved Ejection Fraction | NEJM No benefits and it might be potentially har…
RT @mzkhalil: Beta-Blockers after Myocardial Infarction and Preserved Ejection Fraction | NEJM No benefits and it might be potentially har…
RT @mzkhalil: Beta-Blockers after Myocardial Infarction and Preserved Ejection Fraction | NEJM No benefits and it might be potentially har…
RT @mzkhalil: Beta-Blockers after Myocardial Infarction and Preserved Ejection Fraction | NEJM No benefits and it might be potentially har…
RT @mzkhalil: Beta-Blockers after Myocardial Infarction and Preserved Ejection Fraction | NEJM No benefits and it might be potentially har…
RT @mzkhalil: Beta-Blockers after Myocardial Infarction and Preserved Ejection Fraction | NEJM No benefits and it might be potentially har…
RT @mzkhalil: Beta-Blockers after Myocardial Infarction and Preserved Ejection Fraction | NEJM No benefits and it might be potentially har…
RT @mzkhalil: Beta-Blockers after Myocardial Infarction and Preserved Ejection Fraction | NEJM No benefits and it might be potentially har…
RT @mzkhalil: Beta-Blockers after Myocardial Infarction and Preserved Ejection Fraction | NEJM No benefits and it might be potentially har…
RT @mzkhalil: Beta-Blockers after Myocardial Infarction and Preserved Ejection Fraction | NEJM No benefits and it might be potentially har…
RT @mzkhalil: Beta-Blockers after Myocardial Infarction and Preserved Ejection Fraction | NEJM No benefits and it might be potentially har…
RT @mzkhalil: Beta-Blockers after Myocardial Infarction and Preserved Ejection Fraction | NEJM No benefits and it might be potentially har…
RT @mzkhalil: Beta-Blockers after Myocardial Infarction and Preserved Ejection Fraction | NEJM No benefits and it might be potentially har…
RT @mzkhalil: Beta-Blockers after Myocardial Infarction and Preserved Ejection Fraction | NEJM No benefits and it might be potentially har…
RT @mzkhalil: Beta-Blockers after Myocardial Infarction and Preserved Ejection Fraction | NEJM No benefits and it might be potentially har…
RT @mzkhalil: Beta-Blockers after Myocardial Infarction and Preserved Ejection Fraction | NEJM No benefits and it might be potentially har…
RT @mzkhalil: Beta-Blockers after Myocardial Infarction and Preserved Ejection Fraction | NEJM No benefits and it might be potentially har…
RT @mzkhalil: Beta-Blockers after Myocardial Infarction and Preserved Ejection Fraction | NEJM No benefits and it might be potentially har…
RT @mzkhalil: Beta-Blockers after Myocardial Infarction and Preserved Ejection Fraction | NEJM No benefits and it might be potentially har…
RT @mzkhalil: Beta-Blockers after Myocardial Infarction and Preserved Ejection Fraction | NEJM No benefits and it might be potentially har…
RT @mzkhalil: Beta-Blockers after Myocardial Infarction and Preserved Ejection Fraction | NEJM No benefits and it might be potentially har…
RT @mzkhalil: Beta-Blockers after Myocardial Infarction and Preserved Ejection Fraction | NEJM No benefits and it might be potentially har…
REDUCE-AMI試験(2024年4月) https://t.co/IlEP0rCEb3
RT @mmamas1973: Congratulations to @YndigegnY for a successful defence of his PhD today (1st author of REDUCE-AMI trial https://t.co/jiQN40…
RT @mmamas1973: Congratulations to @YndigegnY for a successful defence of his PhD today (1st author of REDUCE-AMI trial https://t.co/jiQN40…
RT @mmamas1973: Congratulations to @YndigegnY for a successful defence of his PhD today (1st author of REDUCE-AMI trial https://t.co/jiQN40…
RT @mmamas1973: Congratulations to @YndigegnY for a successful defence of his PhD today (1st author of REDUCE-AMI trial https://t.co/jiQN40…
RT @mmamas1973: Congratulations to @YndigegnY for a successful defence of his PhD today (1st author of REDUCE-AMI trial https://t.co/jiQN40…
RT @mmamas1973: Congratulations to @YndigegnY for a successful defence of his PhD today (1st author of REDUCE-AMI trial https://t.co/jiQN40…
Congratulations to @YndigegnY for a successful defence of his PhD today (1st author of REDUCE-AMI trial https://t.co/jiQN40sXEG ) at the University of Lund (I was the external examiner) with supervisors @AlexSchiopu10 and @DavidErlinge This was a public examination with a https://t.co/O6OTqNhG9e
HFpEF にβブロッカー差は見られなかったか…。 https://t.co/OYTzxykmsB
https://t.co/OYTzxykmsB
Everyday_trial# REDUCE-AMI 2024 In patients with acute MI undergoing coronary angiography and found to have normal ejection fraction, longterm beta blockade did not reduce mortality or new MI when compared to no beta blockade. https://t.co/xASstnctmq
心筋梗塞後のβ遮断薬と駆出率の維持 早期冠動脈造影検査を受け、左室駆出率が保たれている(50%以上)急性心筋梗塞の場合、長期のβ遮断薬治療は、複合主要評価項目である全死因死亡または新規心筋梗塞のリスクを低下させることはなかった。 https://t.co/JUDeVFYewl
RT @giovannilandoni: in pts with acute myocardial infarction (undergoing early coronary angiography and with EF≥50%), long-term #betablocke…
in pts with acute myocardial infarction (undergoing early coronary angiography and with EF≥50%), long-term #betablocker treatment did not lead to a⬇️risk of a composite end point (death from any cause or new myocardial infarction) 4/ https://t.co/nFNIcfnZCx
RT @LuisCLCorreia: Interpretação de Evidência: Beta bloqueador no Pós Infarto (Reduce-AMI) https://t.co/OoS1sWskg8 via @YouTube
RT @LuisCLCorreia: Interpretação de Evidência: Beta bloqueador no Pós Infarto (Reduce-AMI) https://t.co/OoS1sWskg8 via @YouTube
Interpretação de Evidência: Beta bloqueador no Pós Infarto (Reduce-AMI) https://t.co/OoS1sWskg8 via @YouTube
Acceso en @PubMedOnline https://t.co/F0nEWKCVsa
RT @AAlMohammad87: Interesting #REDUCE_AMI trial results @NEJM suggesting that #Beta_blockers do not confer reduction of mortality, hospita…
RT @AAlMohammad87: Interesting #REDUCE_AMI trial results @NEJM suggesting that #Beta_blockers do not confer reduction of mortality, hospita…
RT @AAlMohammad87: Interesting #REDUCE_AMI trial results @NEJM suggesting that #Beta_blockers do not confer reduction of mortality, hospita…
Interesting #REDUCE_AMI trial results @NEJM suggesting that #Beta_blockers do not confer reduction of mortality, hospitalisation or HF events if #LVEF was >50% @markcpetrie20 @BSHeartFailure @DrDavidWarriner @hvanspall @TheresaMcDonag3 #CardioTwitter https://t.co/gPaAee8lkU
Un comentario de un usuario de Evidence Alerts sobre https://t.co/X93ST1lNHR: "An important reminder that 'strong evidence' can be ephemeral as knowledge and medical practice advances."
En los pacientes con IAM que tenían una fracción de eyección ventricular izquierda conservada, el tratamiento betabloqueante a largo plazo no conllevó un menor riesgo de muerte o de nuevo IAM. https://t.co/X93ST1lNHR @secardiologia @Sociedad_SEMI
RT @pinacol: 【RCT】LVEF50%以上の冠動脈造影を受けた急性心筋梗塞患者へのβ遮断薬投与は、投与なしと比較して、全原因死亡、心筋梗塞発症の複合転帰リスクを減少させなかった。 #ペ読 https://t.co/odgwKagv1Q
Trending on PubMed: Beta-Blockers after Myocardial Infarction and Preserved Ejection Fraction. https://t.co/6TuekDrEwU
【RCT】LVEF50%以上の冠動脈造影を受けた急性心筋梗塞患者へのβ遮断薬投与は、投与なしと比較して、全原因死亡、心筋梗塞発症の複合転帰リスクを減少させなかった。 #ペ読 https://t.co/odgwKagv1Q
ほんと、HFpEF は治療薬が難しいなあ。 https://t.co/OYTzxykmsB
#MedTwitter I used to think BB were beneficial for up to 3 yrs in CAD after having an MI. Looks like the benefit is in question if LVEF is preserved. No diff for new onset A fib, re-hospitalizatn, or mortality Beta-Blocker after MI & Preserved EF https://t.co/CERlhKKuEN
Los Artículos que debes conocer del #ACC.24 Pt. 1 https://t.co/F22LRDzqYQ vía @YouTube
Beta-Blockers after Myocardial Infarction and Preserved Ejection Fraction https://www.nejm.org/doi/full/10.1056/NEJMoa2401479
DA
GP
TN
E